COWEN AND COMPANY, LLC - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 1 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
COWEN AND COMPANY, LLC ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$24,084,510
-45.1%
2,338,302
-12.2%
1.68%
-53.7%
Q2 2023$43,903,972
+28.4%
2,664,076
-28.6%
3.64%
-9.4%
Q1 2023$34,192,246
+27.9%
3,732,7780.0%4.02%
+43.7%
Q4 2022$26,726,690
+42.9%
3,732,7780.0%2.79%
+56.2%
Q3 2022$18,701,000
+105.3%
3,732,7780.0%1.79%
+103.3%
Q2 2022$9,108,000
-64.3%
3,732,7780.0%0.88%
-64.1%
Q1 2022$25,495,000
-15.5%
3,732,7780.0%2.45%
-10.3%
Q4 2021$30,161,000
+21.9%
3,732,778
+47.8%
2.74%
+133.2%
Q3 2021$24,749,000
+47.4%
2,525,452
+1.2%
1.17%
+33.8%
Q2 2021$16,795,000
-25.6%
2,495,5730.0%0.88%
-43.5%
Q1 2021$22,560,000
+78.5%
2,495,573
+31.9%
1.55%
+37.4%
Q4 2020$12,639,000
+31.6%
1,892,043
-0.7%
1.13%
-28.0%
Q3 2020$9,606,000
-37.7%
1,905,990
-0.1%
1.57%
-38.8%
Q2 2020$15,413,000
+43.2%
1,907,504
+25.7%
2.56%
+3.6%
Q1 2020$10,767,0001,517,2962.47%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q4 2023
NameSharesValueWeighting ↓
WEALTH EFFECTS LLC 2,409,289$24,815,67612.25%
Knoll Capital Management, LLC 600,000$6,180,0006.42%
Vivo Capital, LLC 4,096,428$42,193,2084.62%
GENDELL JEFFREY L 5,615,350$57,838,1053.29%
Tri Locum Partners LP 983,602$10,131,1013.24%
Samsara BioCapital, LLC 967,527$9,965,5283.05%
MPM BioImpact LLC 664,224$6,841,5071.83%
COWEN AND COMPANY, LLC 2,338,302$24,084,5101.68%
RTW INVESTMENTS, LP 7,136,415$73,505,0751.55%
TANG CAPITAL MANAGEMENT LLC 1,000,000$10,300,0001.45%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders